Charles River Laboratories International (CRL) Total Debt: 2009-2025
Historic Total Debt for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $2.2 billion.
- Charles River Laboratories International's Total Debt fell 6.07% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 6.07%. This contributed to the annual value of $2.2 billion for FY2024, which is 15.37% down from last year.
- Per Charles River Laboratories International's latest filing, its Total Debt stood at $2.2 billion for Q3 2025, which was down 6.30% from $2.3 billion recorded in Q2 2025.
- Over the past 5 years, Charles River Laboratories International's Total Debt peaked at $3.0 billion during Q2 2022, and registered a low of $2.2 billion during Q3 2025.
- Over the past 3 years, Charles River Laboratories International's median Total Debt value was $2.5 billion (recorded in 2025), while the average stood at $2.5 billion.
- As far as peak fluctuations go, Charles River Laboratories International's Total Debt skyrocketed by 43.59% in 2021, and later declined by 15.37% in 2024.
- Charles River Laboratories International's Total Debt (Quarterly) stood at $2.7 billion in 2021, then climbed by 1.54% to $2.7 billion in 2022, then fell by 2.23% to $2.6 billion in 2023, then dropped by 15.37% to $2.2 billion in 2024, then dropped by 6.07% to $2.2 billion in 2025.
- Its Total Debt stands at $2.2 billion for Q3 2025, versus $2.3 billion for Q2 2025 and $2.5 billion for Q1 2025.